View in EDS HTML Full Text PDF Full Text

Gut microbiota dysbiosis is associated with altered tryptophan metabolism and dysregulated inflammatory response in COVID-19.

Saved in:
Bibliographic Details
Title: Gut microbiota dysbiosis is associated with altered tryptophan metabolism and dysregulated inflammatory response in COVID-19.
Authors: Essex M; Experimental and Clinical Research Center (ECRC), a cooperation of the Max Delbrück Center and Charité-Universitätsmedizin, Berlin, Germany.; Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.; Charité-Universitätsmedizin Berlin, a corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Millet Pascual-Leone B; Department of Infectious Diseases, Respiratory Medicine and Critical Care, Charité-Universitätsmedizin Berlin, a corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Löber U; Experimental and Clinical Research Center (ECRC), a cooperation of the Max Delbrück Center and Charité-Universitätsmedizin, Berlin, Germany.; Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.; Charité-Universitätsmedizin Berlin, a corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Kuhring M; Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.; Berlin Institute of Health (BIH) at Charité, BIH Metabolomics Platform, Berlin, Germany.; Berlin Institute of Health (BIH) at Charité, Core Unit Bioinformatics, Berlin, Germany., Zhang B; Department of Computational Biology for Individualized Infection Medicine, Center for Individualized Infection Medicine (CiiM), a joint venture between the Helmholtz-Center for Infection Research (HZI) and the Hannover Medical School (MHH), Hannover, Germany.; TWINCORE, joint ventures between the Helmholtz Center for Infection Research (HZI) and the Hannover Medical School (MHH), Hannover, Germany.; College of Life Sciences, Beijing Normal University, Beijing, China., Brüning U; Berlin Institute of Health (BIH) at Charité, BIH Metabolomics Platform, Berlin, Germany., Fritsche-Guenther R; Berlin Institute of Health (BIH) at Charité, BIH Metabolomics Platform, Berlin, Germany., Krzanowski M; Department of Infectious Diseases, Respiratory Medicine and Critical Care, Charité-Universitätsmedizin Berlin, a corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Fiocca Vernengo F; Department of Infectious Diseases, Respiratory Medicine and Critical Care, Charité-Universitätsmedizin Berlin, a corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Brumhard S; Department of Infectious Diseases, Respiratory Medicine and Critical Care, Charité-Universitätsmedizin Berlin, a corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Röwekamp I; Department of Infectious Diseases, Respiratory Medicine and Critical Care, Charité-Universitätsmedizin Berlin, a corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Anna Bielecka A; Department of Microbial Immune Regulation, Helmholtz Center for Infection Research (HZI), Braunschweig, Germany.; German Center for Infection Research (DZIF), partner site Hannover-Braunschweig, Braunschweig, Germany., Lesker TR; Department of Microbial Immune Regulation, Helmholtz Center for Infection Research (HZI), Braunschweig, Germany., Wyler E; Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany., Landthaler M; Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.; Institute of Biology, Humboldt-Universität zu Berlin, Berlin, Germany., Mantei A; Labor Berlin-Charité Vivantes GmbH, Berlin, Germany., Meisel C; Labor Berlin-Charité Vivantes GmbH, Berlin, Germany.; Institute of Medical Immunology, Charité-Universitätsmedizin Berlin, a corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Caesar S; Department of Infectious Diseases, Respiratory Medicine and Critical Care, Charité-Universitätsmedizin Berlin, a corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Thibeault C; Department of Infectious Diseases, Respiratory Medicine and Critical Care, Charité-Universitätsmedizin Berlin, a corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Corman VM; Labor Berlin-Charité Vivantes GmbH, Berlin, Germany.; Institute of Virology, Charité-Universitätsmedizin Berlin, a corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Center for Infection Research (DZIF), Berlin, Germany., Marko L; Experimental and Clinical Research Center (ECRC), a cooperation of the Max Delbrück Center and Charité-Universitätsmedizin, Berlin, Germany.; Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.; Charité-Universitätsmedizin Berlin, a corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Center for Cardiovascular Research (DZHK), partner site Berlin, Berlin, Germany., Suttorp N; Department of Infectious Diseases, Respiratory Medicine and Critical Care, Charité-Universitätsmedizin Berlin, a corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Center for Lung Research (DZL), Berlin, Germany., Strowig T; Department of Computational Biology for Individualized Infection Medicine, Center for Individualized Infection Medicine (CiiM), a joint venture between the Helmholtz-Center for Infection Research (HZI) and the Hannover Medical School (MHH), Hannover, Germany.; Department of Microbial Immune Regulation, Helmholtz Center for Infection Research (HZI), Braunschweig, Germany.; German Center for Infection Research (DZIF), partner site Hannover-Braunschweig, Braunschweig, Germany., Kurth F; Department of Infectious Diseases, Respiratory Medicine and Critical Care, Charité-Universitätsmedizin Berlin, a corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Sander LE; Department of Infectious Diseases, Respiratory Medicine and Critical Care, Charité-Universitätsmedizin Berlin, a corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Center for Lung Research (DZL), Berlin, Germany., Li Y; Department of Computational Biology for Individualized Infection Medicine, Center for Individualized Infection Medicine (CiiM), a joint venture between the Helmholtz-Center for Infection Research (HZI) and the Hannover Medical School (MHH), Hannover, Germany.; TWINCORE, joint ventures between the Helmholtz Center for Infection Research (HZI) and the Hannover Medical School (MHH), Hannover, Germany., Kirwan JA; Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.; Berlin Institute of Health (BIH) at Charité, BIH Metabolomics Platform, Berlin, Germany.; University of Nottingham School of Veterinary Medicine and Science, Loughborough, UK., Forslund SK; Experimental and Clinical Research Center (ECRC), a cooperation of the Max Delbrück Center and Charité-Universitätsmedizin, Berlin, Germany.; Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.; Charité-Universitätsmedizin Berlin, a corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Center for Cardiovascular Research (DZHK), partner site Berlin, Berlin, Germany.; Structural and Computational Biology Unit, European Molecular Biology Laboratory (EMBL), Heidelberg, Germany., Opitz B; Department of Infectious Diseases, Respiratory Medicine and Critical Care, Charité-Universitätsmedizin Berlin, a corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany. bastian.opitz@charite.de.; Labor Berlin-Charité Vivantes GmbH, Berlin, Germany. bastian.opitz@charite.de.; German Center for Lung Research (DZL), Berlin, Germany. bastian.opitz@charite.de.
Source: NPJ biofilms and microbiomes [NPJ Biofilms Microbiomes] 2024 Aug 01; Vol. 10 (1), pp. 66. Date of Electronic Publication: 2024 Aug 01.
Publication Type: Journal Article
Journal Info: Publisher: Nature Publishing Group Country of Publication: United States NLM ID: 101666944 Publication Model: Electronic Cited Medium: Internet ISSN: 2055-5008 (Electronic) Linking ISSN: 20555008 NLM ISO Abbreviation: NPJ Biofilms Microbiomes Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2055-5008
DOI:10.1038/s41522-024-00538-0